Beyond its well-known insulin-sensitizing and blood-glucose-lowering effects in in vitro and in vivo models of T2D, metformin takes pleiotropic actions and exerts multiple health benefits against obesity, cancers, liver diseases, cardiovascular disease, and renal diseases; this has been reviewed elsewhere [18,19]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.